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Just as the activity of many multifunctional proteins is restricted by subcellular localization, so is their regu-
lation. In this issue of Development Cell, Starostina et al. identify an E3 ubiquitin ligase, CRL2LRR1, for the cy-
clin-dependent kinase inhibitor p21 that specifically ubiquitylates cytoplasmic p21 to facilitate cell migration.The ubiquitin system covalently attaches
ubiquitin to substrate proteins, leading to
either a nonproteolytic change of function
or degradation by the 26S proteosome.
While a limited number of E1-activating
and E2-conjugating enzymes are em-
ployed by the system, more than a thou-
sand distinct E3 ubiquitin ligases are
present in higher eukaryotes to regulate
a wide range of cellular process. Protea-
somes and E3 ligases are present in
both the nucleus and the cytosol, and
ubiquitin-mediated degradation occurs
in both compartments. There have been,
however, relatively few examples of local-
ized ubiquitylation reported thus far. Two
notable examples are p53 and b-catenin,
transcription factors that can be exported
out of the nucleus for degradation in the
cytoplasm. This nuclear export and cyto-
plasmic ubiquitylation ensures that the
function of the transcription factor is
geographically separated from its degra-
dation to avoid promiscuous degradation
and to allow rapid activation of the factor
in response to signaling events by simply
blocking export and ubiquitylation. Re-
porting in this issue of Developmental
Cell, Starostina and colleagues (2010)
now identify a specific E3 ligase for the
degradation of cytoplasmic p21 in human
cells, providing evidence that distinct
functions of an individual protein in
different cellular compartments can be
regulated by different E3 ligases.
At the heart of this study is
p21CIP1/WAF1, best known as a transcrip-
tional target of p53 following DNA
damage and other cellular stresses. p21
induces a G1 cell-cycle arrest by inhibit-
ing cyclin-dependent kinases (CDKs) in
the nucleus. Additional functions for p21
and its cousin p27KIP1 were uncovered
by a number of studies reporting cyto-
plasmic accumulation of the proteins inmultiple types of human tumors, suggest-
ing that p21 and p27 could function as
tumor suppressors in the nucleus and on-
coproteins in the cytoplasm (Besson
et al., 2004). The cytoplasmic function of
p21 is not dependent on its ability to
inhibit CDKs but rather is linked to actin
cytoskeleton regulation. Cytoplasmic
p21 inhibits the Rho-associated kinase,
ROCK1, uncoupling Rho-GTPase activity
from stress fiber formation and promoting
cytoskeleton remodeling and cell motility.
Are these distinctive nuclear and cyto-
plasmic functions of p21 differentially
regulated? The study by Starostina et al.
(2010) provides compelling evidence sup-
porting just such a model.
In a search for proteins that interact
with Caenorhabditis elegans CUL2, a
member of evolutionary conserved cullin
family proteins that function as scaffold
for the assembly of cullin-RING E3 ligases
(CRLs), Starostina et al. (2010) identified
by affinity purification the leucine-rich
repeat protein 1 (LRR1), a VHL-box
protein brought to the CUL2 complex via
its interaction with the CUL2 linker
protein, elongin C (Figure 1). The authors
previously showed that in C. elegans,
cul-2 mutants exhibit a germline defect,
with germ cells arrested in G1 (Feng
et al., 1999). This defect could be partially
rescued by the haploid deletion of cki-1,
the C. elegans homolog of mammalian
p27, suggesting that it is a downstream
effector of CUL2 function. Starostina and
colleagues (2010) observed that mutation
of lrr-1 was phenotypically similar to cul-2
mutation, resulting in accumulation of
CKI-1. Likewise, the G1 arrest defect of
germ cells in lrr-1 mutants was partially
rescued by deletion of one cki-1 allele.
Furthermore, the authors found that
LRR1 physically binds to CKI-1, and its
overexpression increased CKI-1 proteinDevelopmental Cell 19, Nturnover. Collectively, these genetic and
biochemical data are consistent with the
notion that in C. elegans, LRR-1 functions
to promote the G1 to S progression by
serving as substrate receptor to target
CKI-1 for ubiquitylation by the CRL2LRR1
E3 ligase (Figure 1).
The authors then investigated the func-
tion of mammalian LRR1 and found that
knocking down LRR1 selectively in-
creased the protein level of p21 but not
the related CDK inhibitors p27 and p57.
Surprisingly, unlike in C. elegans cells,
depletion of either LRR1 or CUL2 in
human cells did not cause an obvious
cell cycle arrest. This unexpected finding
led the authors to examine CRL2LRR1
activity specifically in cytoplasm, where
p21 functions to regulate ROCK1 inde-
pendent of its role in cell-cycle regulation.
They found that cytoplasmic p21 did
indeed accumulate in response to knock-
down of either LRR1 or CUL2. Further-
more, LRR1 or CUL2 knockdown de-
creased stress fibers and cell-cell
contacts while increasing F-actin at the
cell periphery and cell motility, consistent
with a role for the protein in regulating
cytoplasmic p21. Importantly, these
morphological changes in LRR1-knock-
down cells were suppressed by codeple-
tion of p21.
Three different E3 ubiquitin ligases have
been previously identified in targeting p21
degradation (Figure 1): SCFSKP2 (Born-
stein et al., 2003; Wang et al., 2005; Yu
et al., 1998), APC/CCDC20 (Amador et al.,
2007), and CRL4CDT2 (Abbas et al., 2008;
Kim et al., 2008; Nishitani et al., 2008).
Given that SKP2, CDC20, and CDT2—
the substrate recognition subunits for
the respective E3 ligase complexes—are
all nuclear proteins, these E3s probably
ubiquitylate only nuclear p21. No
evidence links these three E3 ligasesovember 16, 2010 ª2010 Elsevier Inc. 641
Figure 1. Multiple E3 ligases target human p21 ubiquitylation in different cellular compartments
Four E3 ligases—SCFSKP2, APC/CCDC20, CRL4CDT2, and CRL2LRR1—are involved in p21 ubiquitylation and destruction. Unlike the three previously identified E3
ligases, which act on p21 in the nucleus in the context of cell-cycle regulation, CRL2LRR1 targets p21 in the cytoplasm to control cell migration. All four E3 ligases
are all composed of multiple subunits, including a scaffold (green) that binds to a small RNG finger protein, ROC1/RBX1 or APC11 (red), which in turn brings in and
allosterically activates a ubiquitin (Ub)-conjugating enzyme, E2 (brown). A separate domain in the scaffold binds to a linker protein (blue) that interacts with
a protein motif (orange) present in substrate receptors (black).
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Previewswith either the ubiquitylation of cyto-
plasmic p21 or the regulation of cytoskel-
eton and cell motility, making the
CRL2LRR1 the first E3 ligase specific for
cytoplasmic p21.
The study by Starostina et al. (2010) rai-
ses several interesting questions. Despite
the important function of CRL2LRR1 in
regulating cytoskeleton dynamics and
cell migration, this function is not
conserved in C. elegans. No obvious cell
migration defect was detected by the
authors in C. elegans lrr-1mutants. More-
over, C. elegans LRR1 is localized to the
nucleus. How broadly does the CRL2LRR1
E3 ligase target cytoplasmic p21? Did
CRL2LRR1-mediated cytoplasmic p21
ubiquitylation evolve after the acquisition
of the cytoplasmic CIP/KIP function that
is restricted to mammalian cells? Target-
ing the ubiquitylation of an individual
protein with multiple E3 ligases is not
unique to p21—at least three E3 ligases
(SCFSKP2, KPC, and CRL4) are involved642 Developmental Cell 19, November 16, 20in p27 ubiquitylation, and more than
a dozen are linked to p53 ubiquitylation.
So how do cells coordinate between
different E3 ligases, especially when the
physiological outcomes of this differential
targeting are distinct? The answer prob-
ably rests in the upstream trigger that
leads to the binding of the substrate to
its receptor, an issue that has not been
addressed by the current work but the
analysis of which is an important next
step in understanding the pathways that
orchestrate p21’s varied functions.
The finding by Starostina et al. (2010) of
targeted protein degradation in a specific
subcellular compartment also suggests
that the function of some E3 ligases may
escape detection by commonly used
techniques such as western blotting of
whole-cell or tissue lysates. Subcellular
fractionation or immunohistochemistry
may be needed for studying substrates
or recognition factors that are known
to localize to a specific compartment.10 ª2010 Elsevier Inc.Lastly, the work of Starostina et al.
(2010) may have implications for tumori-
genesis. LRR1 has thus far not been well
characterized, but, as the authors note,
it is located on human chromosome
14q21.3, a region that is lost in several
types of metastatic tumors. Given that
cytoplasmic accumulation of p21 facili-
tates cell migration and potentially tumor
metastasis, one wonders whether LRR1
functions to suppress late stages of
tumorigenesis.REFERENCES
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Anthrax toxins cause vascular dysfunction, in part by perturbing the endothelial cell barrier. Reporting in
Nature, Guichard et al. shed new light on the mechanism by which this occurs and show that anthrax toxins
interferewith exocytic delivery of cadherins to endothelial cell junctionsby antagonizing the exocyst complex.The bacterium Bacillus anthracis is the
causative agent of anthrax—an often
lethal disease characterized by vascular
collapse (Moayeri and Leppla, 2009).
Two toxins, lethal toxin (LT) and edema
toxin (ET), play critical roles in systemic
anthrax. The toxic moieties of LT and ET
are known as lethal factor (LF) and edema
factor (EF), respectively. LF is zinc-depen-
dent metalloprotease that cleaves MAP
kinase kinase (MAPKK) proteins, thereby
interfering with cellular signal transduc-
tion pathways. EF is a calmodulin-depen-
dent adenylate cyclase that affects cell
physiology by elevating cyclic AMP
(cAMP) levels. Vascular endothelial cells
are thought to be an important target for
LT and ET, as adverse effects on the
barrier function of these cells could, in
part, account for the vascular leakage
that typifies systemic anthrax (Moayeri
and Leppla, 2009). Indeed, LT causes
a loss of endothelial cell barrier function
(Warfel et al., 2005). Interestingly, LT-
mediated inhibition of barrier function is
correlated with decreased surface ex-
pression of the adherens junction protein,
vascular endothelial cadherin. Altogether
these findings suggest that LT and
perhaps ET might impair the function of
vascular endothelium, in part by downre-gulating a key molecule involved in cell-
cell adhesion. However, the molecular
mechanism bywhich anthrax toxins affect
cadherin distribution in endothelial cells
was not understood. Recent findings by
Guichard and colleagues (2010), pub-
lished in Nature, have shed light on this
important topic. The authors found that
LT and ET impair the delivery of cadherins
from intracellular vesicles to adherens
junctions. These toxins perturb trafficking
by interfering with the function of a multi-
protein complex called the exocyst.
The exocyst is an evolutionarily con-
served eight-subunit complex comprised
of Sec3, Sec5, Sec6, Sec8, Sec10,
Sec15, Exo70, and Exo84 (Wu et al.,
2008). This complex promotes exocytosis
by mediating tethering and fusion of intra-
cellular vesicles with sites in the plasma
membrane. Exocyst activity is regulated
by several small GTPases, including
Rab11, which interacts with Sec15 and
mediates the transport of vesicles from
a specialized endosomal compartment
called the recycling endosome to the
plasma membrane. The route that led
to the discovery that anthrax toxins
antagonize the exocyst is fascinating and
serves as a prime example of how
simplified animal models can be usefulin understandingbacterial virulencemech-
anisms. In previous work, the same group
expressed EF and LF in Drosophila mela-
nogaster and found that these
toxins caused phenotypes consistent
with their known effects on MAP kinase-
and cAMP-mediated signaling (Guichard
et al., 2006). These initial findings sug-
gested that EF and LF are active in the fruit
fly and that this organism might therefore
beausefulmodel for probing thebiological
function of anthrax toxins. In their current
study, Guichard et al. (2010) found that,
when expressed in Drosophila, EF or LF
elicit phenotypes that resemble inhibition
of the Notch signaling pathway (Fortini,
2009). A previous study by another group
indicated a role for Rab11 and Sec15 in
plasma membrane delivery of the Notch
ligand Delta (Jafar-Nejad et al., 2005).
Inspired by these findings, Guichard and
colleagues performed a series of elegant
genetic studies leading to the conclusion
that EF interferes with Notch signaling
by antagonizing Rab11. Both EF and LF
were found to impair the formation
of Sec15-containing vesicles and the
delivery of DE-cadherin to adherens
junctions in Drosophila cells. The authors’
findings inDrosophila led them to examine
the effect of anthrax toxins on exocyticovember 16, 2010 ª2010 Elsevier Inc. 643
